Medizinstudium

09/2004 - 031/2011 Studium der Humanmedizin, Universita´ Politecnica delle Marche, Ancona, Italien

Beruflicher Werdegang

Assistenzarzt seit 07/2019
Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München,
Univ.-Prof Dr. H. Friess

seit 07/2019
Assistenzärztin in der Chirurgischen Klinik, Klinikum rechts der Isar, Technische Universität München,
(Univ.-Prof. Dr. H. Friess)

12/2018 – 06/2019
Wissenschaftliche Mitarbeiterin im Pankreaslabor, Klinik und Poliklinik für Chirurgie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland

08/2015 – 02/2017
Wissenschaftliche Mitarbeiterin in der „Andrew L. Warshaw Institut für Pankreas Karzinom“ (Tutor: Dr. Carlos Fernandez del-Castillo), Department of Surgery, Massachusetts General Hospital (MGH), Harvard Medical School (HMS), Boston, USA

07/2012 – 07/2018
Weiterbildung zum Facharzt für Chirurgie, Università Politecnica delle Marche (UNIVPM), Ancona, Italien

Wissenschaftlicher Schwerpunkt

Intraduktale papillär-muzinöse Neoplasie (IPMN) des Pankreas, Pankreaskarzinom, Neuroendokrine Pankreastumoren (PNETs)

Publikationen

Suche nach Autor Pergolini I bei PubMed

Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-del Castillo C. “LONG-TERM RISK OF PANCREATIC MALIGNANCY IN PATIENTS WITH BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM IN A REFERRAL CENTER” Gastroenterology. 2017 Nov;153(5):1284-1294.

Pergolini I, Morales-Oyarvide V, Mino-Kenudson M, Honselmann KC, Rosenbaum M, Nahar S, Kem M, Ferrone CR, Lillemoe KD, Bardeesy N, Ryan DP, Thayer SP, Warshaw AL, Fernandez del-Castillo C, Liss AS. “TUMOR ENGRAFTMENT IN PATIENT-DERIVED XENOGRAFTS OF PANCREATIC DUCTAL ADENOCARCINOMA IS ASSOCIATED WITH ADVERSE CLINICOPATHOLOGICAL FEATURES AND POOR SURVIVAL” PLoS One. 2017 Aug 30;12(8):e0182855.

Yang KS, Im H, Hong S, Pergolini I, Fernandez del Castillo A, Clardy S, Huang CH, Pille C, Ferrone S, Yang R, Castro C, Lee H, Fernández-del Castillo C, Weissleder R. “MULTI-PARAMETRIC PLASMA EV PROFILING FACILITATES DIAGNOSIS OF PANCREATIC MALIGNANCY” Sci Transl Med. 2017 May 24;9(391).

Michelakos T, Pergolini I, Castillo CF, Honselmann KC, Cai L, Deshpande V, Wo JY, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Nipp RD, Parikh A, Qadan M, Warshaw AL, Hong TS, Lillemoe KD, Ferrone CR. “PREDICTORS OF RESECTABILITY AND SURVIVAL IN PATIENTS WITH BORDERLINE AND LOCALLY ADVANCED PANCREATIC CANCER WHO UNDERWENT NEOADJUVANT TREATMENT WITH FOLFIRINOX.” Ann Surg. 2019 Apr;269(4):733-740.

Honselmann KC, Pergolini I, Castillo CF, Deshpande V, Ting D, Taylor MS, Bolm L, Qadan M, Wellner U, Sandini M, Bausch D, Warshaw AL, Lillemoe KD, Keck T, Ferrone CR. “TIMING BUT NOT PATTERNS OF RECURRENCE IS DIFFERENT BETWEEN NODE-NEGATIVE AND NODE-POSITIVE RESECTED PANCREATIC CANCER.” Ann Surg. 2019 Jan 18.

Attiyeh MA, Fernández-del Castillo C, Al Efishat M, Eaton AA, Gönen M, Pergolini I, Rezaee N, Lillemoe KD, Ferrone CR, Mino-Kenudson M, Weiss MJ, Cameron JL, Hruban RH, D’Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Wolfgang CL, Allen PJ. “DEVELOPMENT AND VALIDATION OF A MULTI-INSTITUTIONAL PREOPERATIVE NOMOGRAM FOR PREDICTING GRADE OF DYSPLASIA IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (IPMNS) OF THE PANCREAS: A REPORT FROM THE PANCREATIC SURGERY CONSORTIUM.” Ann Surg. 2018 Jan;267(1):157-163.

Crippa S, Pergolini I, Rubini C, Castelli P, Partelli S, Zardini C, Marchesini G, Zamboni G, Falconi M. (co-first author) “RISK OF MISDIAGNOSIS AND OVERTREATMENT IN PATIENTS WITH MAIN PANCREATIC DUCT DILATATION AND SUSPECTED COMBINED/MAIN-DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS” Surgery. 2016 Apr;159(4):1041-9.